Zinc Phenolsulfonate

Zinc Phenolsulfonate

AKA “Benzenesulfonic acid, 4-hydroxy-, zinc salt (2:1), HSDB 2551, EINECS 204-867-8, Zinc bis(4-hydroxybenzenesulphonate), UNII-4O71YT5YB5, EPA Pesticide Chemical Code 089002, zinc phenolsulphonate, 4O71YT5YB5, Zinc phenolsulfonate [NF]”

Ingredient

Ingredient Facts

Zinc phenolsulfonate

AKA: Benzenesulfonic acid, 4-hydroxy-, Zinc salt (2:1), HSDB 2551, EINECS 204-867-8, Zinc bis(4-hydroxybenzenesulphonate), UNII-4O71YT5YB5, EPA Pesticide Chemical Code 089002, Zinc phenolsulphonate, 4O71YT5YB5, Zinc phenolsulfonate [NF]

Ingredient · Antimicrobial · EWG: 5

Synthetic

Preservative

Astringent

Not Clean

Zinc bis(4-hydroxybenzenesulphonate)

Solubility Solubility: 62.5 g/100 cc cold water; 250 g/100 cc water at 100 °C; 55.6 g/100 cc alcohol at 25 °C /Octahydrate/

Formula

C12H10O8S2Zn

Mol. Weight

411.70

CAS #

127-82-2

Form

Powder

State

Zinc phenolsulfonate appears as a colorless to white crystalline solid which turns pink on exposure to air. The primary is the threat to the environment. Immediate steps should be taken to limit its s

See origin →

Functions

Antimicrobial

Keeps your product from growing bacteria, mold, or yeast. Without these, that jar of cream becomes a petri dish in about a week.

Astringent

Tightens and contracts skin tissue, temporarily shrinking pores and reducing oiliness. That "clean, tight" feeling after toner.

Deodorant

Controls excess oil

Fights acne

Causing bacteria

Minimizes pores

Traditional Use

A synthetic compound developed in the 20th century combining zinc with phenolic chemistry. Used in antiseptic and astringent cosmetic formulations, particularly for problem skin.

Skin Types

●all-skin-types

Best For

Acne

Pregnancy & Breastfeeding Safe

Caution

EWG

CIR

Safe as used

Pregnancy

Caution

CIR Safety Findings

Not a Sensitizer

medical-approval

all-shades-safe

Concentration Guide

6%

0%8%

Reg. Limit

EU regulatory limit: 6%. % of anhydrous substance). Avoid contact with eyes Source: EU Cosmetics Regulation (EC) 1223/2009, Annex III (Restricted Substances), Entry 25.